Your RSA-2048 keys break in 2030. Find every one of them before attackers do.
🛡️
Not in CISA KEV
HIGH severity

CVE-2026-100561 — Openclaw

HIGH

CVE-2026-100561 is a high-severity (CVSS 8) CWE-88 vulnerability. No vendor fix is recorded yet; mitigation options are listed below.

OpenClaw (npm package 'openclaw') versions >= 2026.3.22 and < 2026.8.1 contain an approval-bypass flaw in the exec approval policy: the policy could trust a command-running wrapper…

Published
Sep 26, 2026
Updated
Sep 26, 2026
Affected
—
Patched
—
Exploits
None indexed
Exploitation data as of Sep 26, 2026 · OSV.dev, NVD, FIRST.org (EPSS)

Description

OpenClaw (npm package 'openclaw') versions >= 2026.3.22 and < 2026.8.1 contain an approval-bypass flaw in the exec approval policy: the policy could trust a command-running wrapper without inspecting the command carried in its arguments. After an operator allowlisted or permanently approved a benign wrapper invocation, a later agent turn could substitute an arbitrary inner command and execute it with the OpenClaw process's host privileges without a further approval prompt. Exploitation requires the relevant wrapper to resolve on the host and a prior operator decision allowing that wrapper. Transparent shell carriers and opaque utilities such as process monitors, tracers, namespace tools, and proxy wrappers were affected through related trust-resolution gaps. Fixed in 2026.8.1.

Detection & mitigation playbook

Vulnerability
  1. Detect

    Identify every host running the affected component and compare the installed build against the fixed version below — for source-built or distro-packaged software the version string, not a lockfile, is the source of truth (`dpkg -l`, `rpm -q`, or the binary's own `--version`). Because exploitation targets the running service rather than your application code, O3 also flags the exploit behaviour from runtime telemetry and egress traffic.

  2. Remediation status

    No fixed release is recorded for CVE-2026-100561 yet. Track the upstream advisory, and apply the exposure-reduction steps below in the meantime.

  3. Mitigate without a patch

    Reduce reachability while you patch: restrict network access to the service to trusted sources, disable or gate the affected component where your deployment allows it, and add a WAF/IPS signature if one exists for CVE-2026-100561. O3's runtime protection blocks the cwe-88 flaw at execution, which holds the line on hosts you cannot patch immediately.

  4. How O3 protects you

    O3 detects and blocks CVE-2026-100561 exploitation at runtime with eBPF exploit-chain detection, plus L7 egress monitoring that catches a post-exploitation callback and cuts the attacker's outbound channel.

Tailored to CVE-2026-100561. Runtime protection reduces exposure until a permanent patch is applied and verified — it complements patching, it doesn't replace it.

Frequently Asked Questions

OpenClaw (npm package 'openclaw') versions >= 2026.3.22 and < 2026.8.1 contain an approval-bypass flaw in the exec approval policy: the policy could trust a command-running wrapper without inspecting the command carried in its arguments. After an operator allowlisted or permanently approved a benign wrapper invocation, a later agent turn could substitute an arbitrary inner command and execute it with the OpenClaw process's host privileges without a further approval prompt. Exploitation requires the relevant wrapper to resolve on the host and a prior operator decision allowing that wrapper. Tra
O3 Security · Impact-Aware SCA

Is CVE-2026-100561 in your dependencies?

O3 Security finds CVE-2026-100561 across dependencies, including transitive ones, and its impact-aware SCA ranks findings by whether your code actually calls the vulnerable path.

CVE-2026-100561: Openclaw (High 8) | O3 Security